Your browser doesn't support javascript.
loading
Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis.
Brehaut, Eliana; Neupane, Dipika; Levis, Brooke; Wu, Yin; Sun, Ying; Krishnan, Ankur; He, Chen; Bhandari, Parash Mani; Negeri, Zelalem; Riehm, Kira E; Rice, Danielle B; Azar, Marleine; Yan, Xin Wei; Imran, Mahrukh; Chiovitti, Matthew J; Saadat, Nazanin; Cuijpers, Pim; Ioannidis, John P A; Markham, Sarah; Patten, Scott B; Ziegelstein, Roy C; Henry, Melissa; Ismail, Zahinoor; Loiselle, Carmen G; Mitchell, Nicholas D; Tonelli, Marcello; Boruff, Jill T; Kloda, Lorie A; Beraldi, Anna; Braeken, Anna P B M; Carter, Gregory; Clover, Kerrie; Conroy, Ronán M; Cukor, Daniel; da Rocha E Silva, Carlos E; De Souza, Jennifer; Downing, Marina G; Feinstein, Anthony; Ferentinos, Panagiotis P; Fischer, Felix H; Flint, Alastair J; Fujimori, Maiko; Gallagher, Pamela; Goebel, Simone; Jetté, Nathalie; Julião, Miguel; Keller, Monika; Kjærgaard, Marie; Love, Anthony W; Löwe, Bernd.
Affiliation
  • Brehaut E; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: eliana.brehaut@mail.mcgill.ca.
  • Neupane D; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada. Electronic address: dipika.neupane@mail.mcgill.ca.
  • Levis B; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Centre for Prognosis Research, School of Primary, Community and Social Care, Keele University,
  • Wu Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada. Electronic address: yin
  • Sun Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: ying.sun2@mail.mcgill.ca.
  • Krishnan A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: ankur.krishnan@mail.mcgill.ca.
  • He C; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: chen.he3@mail.mcgill.ca.
  • Bhandari PM; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada. Electronic address: parash.bhandari@mail.mcgill.ca.
  • Negeri Z; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada. Electronic address: zelalem.negeri@mail.mcgill.ca.
  • Riehm KE; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: kirariehm@gmail.com.
  • Rice DB; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Psychology, McGill University, Montréal, Québec, Canada. Electronic address: danielle.rice@mail.mcgill.ca.
  • Azar M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada. Electronic address: marleine.azar@mail.mcgill.ca.
  • Yan XW; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: xin.yan@mail.mcgill.ca.
  • Imran M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: mahrukh.imran@mail.mcgill.ca.
  • Chiovitti MJ; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: matthew.chiovitti@mail.mcgill.ca.
  • Saadat N; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: nazanin.saadat@mail.mcgill.ca.
  • Cuijpers P; Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands. Electronic address: p.cuijpers@vu.nl.
  • Ioannidis JPA; Department of Medicine, Department of Epidemiology and Population Health, Department of Biomedical Data Science, Department of Statistics, Stanford University, Stanford, CA, USA. Electronic address: jioannid@stanford.edu.
  • Markham S; Department of Biostatistics and Health Informatics, King's College London, London, UK. Electronic address: sarah.markham@kcl.ac.uk.
  • Patten SB; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, Canada; Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary, Calgary, Canada. Electronic
  • Ziegelstein RC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: rziegel2@jhmi.edu.
  • Henry M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. Electronic address: melissa.henry@mcgill.ca.
  • Ismail Z; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Department of Psychiatry, Clinical Neuroscience and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Cumming School of Medicine, University of Calgary, Calga
  • Loiselle CG; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Ingram School of Nursing, McGill University, Montréal, Québec, Canada; Centre for Nursing Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Oncology, Faculty of Medicine, McGill Uni
  • Mitchell ND; Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada; Alberta Health Services, Edmonton, Alberta, Canada. Electronic address: ndm@ualberta.ca.
  • Tonelli M; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: cello@ucalgary.ca.
  • Boruff JT; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, Quebec, Canada. Electronic address: jill.boruff@mcgill.ca.
  • Kloda LA; Library, Concordia University, Montréal, Québec, Canada. Electronic address: lorie.kloda@concordia.ca.
  • Beraldi A; kbo Lech-Mangfall-Klinik für Psychatrie, Psychotherapie und Psychsomatik, Garmisch-Partenkirchen, Bayern, Germany. Electronic address: Anna.Beraldi@psychiatrie-gap.de.
  • Braeken APBM; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands; Department of Health Services Research, CAPHRI Sch
  • Carter G; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Calvary Mater Newcastle, Australia. Electronic address: Gregory.Carter@newcastle.edu.au.
  • Clover K; Centre for Brain and Mental Health Research, University of Newcastle, Callaghan, NSW, Australia. Electronic address: Kerrie.Clover@calvarymater.org.au.
  • Conroy RM; Royal College of Surgeons in Ireland Division of Population Health Sciences, Dublin, Ireland. Electronic address: rconroy@rcsi.com.
  • Cukor D; Rogosin Institute, New York, NY, USA. Electronic address: dac9227@nyp.org.
  • da Rocha E Silva CE; Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: ceduardodarochaesilva@gmail.com.
  • De Souza J; Birmingham and Solihull Mental Health Foundation Trust, Birmingham, UK; University of Birmingham, Birmingham, UK. Electronic address: jennifer.desouza@nhs.net.
  • Downing MG; School of Psychological Sciences, Monash University, Melbourne, VIC, Australia; Monash Epworth Rehabilitation Research Centre, Epworth HealthCare, Melbourne, VIC, Australia. Electronic address: marina.downing@monash.edu.
  • Feinstein A; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Electronic address: ant.feinstein@utoronto.ca.
  • Ferentinos PP; 2nd Department of Psychiatry, Attikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK. Electronic address: pferentinos@med.uoa.gr.
  • Fischer FH; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, B
  • Flint AJ; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network, Toronto, Ontario, Canada. Electronic address: Alastair.Flint@uhn.ca.
  • Fujimori M; Section of Psychological Science, Division of Health Care Research, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan. Electronic address: mfujimor@ncc.go.jp.
  • Gallagher P; School of Psychology, Dublin City University, Dublin, Ireland. Electronic address: pamela.gallagher@dcu.ie.
  • Goebel S; Department of Clinical Psychology and Psychotherapy, Institute of Psychology, Christian-Albrechts University, Kiel, Germany. Electronic address: simone.goebel@web.de.
  • Jetté N; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electroni
  • Julião M; Equipa Comunitária de Suporte em Cuidados Paliativos de Sintra, Portugal. Electronic address: migueljuliao@gmail.com.
  • Keller M; Division of Psychooncology, Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Germany. Electronic address: monika.keller@uni-heidelberg.de.
  • Kjærgaard M; Endocrinology Research Group, Medical Clinic, University Hospital of North Norway, Norway; Department of Internal Medicine, Kolding Hospital, Hospital Lillebaelt, Denmark. Electronic address: marianguaq@gmail.com.
  • Love AW; Department of Psychology, Victoria University, Victoria, Australia. Electronic address: anthony.love@vu.edu.au.
  • Löwe B; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: b.loewe@uke.de.
J Psychosom Res ; 139: 110256, 2020 12.
Article in En | MEDLINE | ID: mdl-33069051
OBJECTIVES: Validated diagnostic interviews are required to classify depression status and estimate prevalence of disorder, but screening tools are often used instead. We used individual participant data meta-analysis to compare prevalence based on standard Hospital Anxiety and Depression Scale - depression subscale (HADS-D) cutoffs of ≥8 and ≥11 versus Structured Clinical Interview for DSM (SCID) major depression and determined if an alternative HADS-D cutoff could more accurately estimate prevalence. METHODS: We searched Medline, Medline In-Process & Other Non-Indexed Citations via Ovid, PsycINFO, and Web of Science (inception-July 11, 2016) for studies comparing HADS-D scores to SCID major depression status. Pooled prevalence and pooled differences in prevalence for HADS-D cutoffs versus SCID major depression were estimated. RESULTS: 6005 participants (689 SCID major depression cases) from 41 primary studies were included. Pooled prevalence was 24.5% (95% Confidence Interval (CI): 20.5%, 29.0%) for HADS-D ≥8, 10.7% (95% CI: 8.3%, 13.8%) for HADS-D ≥11, and 11.6% (95% CI: 9.2%, 14.6%) for SCID major depression. HADS-D ≥11 was closest to SCID major depression prevalence, but the 95% prediction interval for the difference that could be expected for HADS-D ≥11 versus SCID in a new study was -21.1% to 19.5%. CONCLUSIONS: HADS-D ≥8 substantially overestimates depression prevalence. Of all possible cutoff thresholds, HADS-D ≥11 was closest to the SCID, but there was substantial heterogeneity in the difference between HADS-D ≥11 and SCID-based estimates. HADS-D should not be used as a substitute for a validated diagnostic interview.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Depression / Depressive Disorder, Major Type of study: Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Psychosom Res Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Depression / Depressive Disorder, Major Type of study: Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Psychosom Res Year: 2020 Type: Article